Receptor-bound conformation of cilengitide better represented by its solution-state structure than the solid-state structure.

The X-ray crystal and NMR spectroscopic structures of the peptide drug candidate Cilengitide (cyclo(RGDf(NMe)Val)) in various solvents are obtained and compared in addition to the integrin receptor bound conformation. The NMR-based solution structures exhibit conformations closely resembling the X-ray structure of Cilengitide bound to the head group of integrin αvβ3. In contrast, the structure of pure Cilengitide recrystallized from methanol reveals a different conformation controlled by the lattice forces of the crystal packing. Molecular modeling studies of the various ligand structures docked to the αvβ3 integrin revealed that utilization of the solid-state conformation of Cilengitide leads-unlike the solution-based structures-to a mismatch of the ligand-receptor interactions compared with the experimentally determined structure of the protein-ligand complex. Such discrepancies between solution and crystal conformations of ligands can be misleading during the structure-based lead optimization process and should thus be taken carefully into account in ligand orientated drug design.

[1]  B. Reif,et al.  The conformation of cyclo(-D-Pro-Ala4-) as a model for cyclic pentapeptides of the DL4 type. , 2006, Journal of the American Chemical Society.

[2]  D. Seebach,et al.  Complexation and medium effects on the conformation of cyclosporin A studied by NMR spectroscopy and molecular dynamics calculations. , 1990, Biochemical pharmacology.

[3]  Stephen W. Fesik,et al.  A model of the cyclophilin/cyclosporin A (CSA) complex from NMR and X-ray data suggests that CSA binds as a transition-state analog , 1992 .

[4]  J. Blunt,et al.  Different solution and solid‐state conformations of the antibiotic cycloheximide , 1989 .

[5]  Lara C. Spencer,et al.  Crystallographic characterization of helical secondary structures in alpha/beta-peptides with 1:1 residue alternation. , 2008, Journal of the American Chemical Society.

[6]  H. Kessler,et al.  N-methylated cyclic pentaalanine peptides as template structures. , 2006, Journal of the American Chemical Society.

[7]  Horst Kessler,et al.  Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation , 2010, Anti-cancer agents in medicinal chemistry.

[8]  Thilo Stehle,et al.  Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand , 2002, Science.

[9]  H. Balaram,et al.  Conformational transitions in a Pro-Pro peptide on dissolution of single crystals. , 1982, Biochemical and biophysical research communications.

[10]  M. Ghadiri,et al.  Self-Assembling Cyclic β3-Peptide Nanotubes as Artificial Transmembrane Ion Channels , 1998 .

[11]  H. Kessler,et al.  Conformational preference and potential templates of N-methylated cyclic pentaalanine peptides. , 2008, Chemistry.

[12]  Juan R. Granja,et al.  Self-assembling organic nanotubes based on a cyclic peptide architecture , 1993, Nature.

[13]  Timothy F. Havel.  An evaluation of computational strategies for use in the determination of protein structure from distance constraints obtained by nuclear magnetic resonance. , 1991, Progress in biophysics and molecular biology.

[14]  R. W. Janes,et al.  A comparison of X‐ray and NMR structures for human endothelin‐1 , 1995, Protein science : a publication of the Protein Society.

[15]  J. Engel,et al.  Does a Molecule have the Same Conformation in the Crystalline State and in Solution? Comparison of NMR Results for the Solid State and Solution with those of the X‐ray Structural Determination , 1981 .

[16]  H. Kessler,et al.  Conformation of Antamanide , 1989 .

[17]  Berk Hess,et al.  GROMACS 3.0: a package for molecular simulation and trajectory analysis , 2001 .

[18]  Horst Kessler,et al.  N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists , 1999 .

[19]  Horst Kessler,et al.  Structure Refinement of Cyclosporin A in Chloroform by Using RDCs Measured in a Stretched PDMS‐Gel , 2005, Chembiochem : a European journal of chemical biology.

[20]  P. Balaram,et al.  Multiple conformational states in crystals and in solution in alphagamma hybrid peptides. Fragility of the C12 helix in short sequences. , 2008, The Journal of organic chemistry.

[21]  E. Querol,et al.  NMR studies of the conformation of thiocellobiose bound to a β‐glucosidase from Streptomyces sp , 1998, FEBS letters.

[22]  W. S. Sheldrick,et al.  Ist die Konformation eines Moleküls im Kristall und in Lösung gleich? NMR‐Befunde an Festkörper und Lösung im Vergleich zur Röntgen‐Strukturbestimmung , 1981 .

[23]  Juan R. Granja,et al.  Self-Assembling Peptide Nanotubes , 1996 .

[24]  C. Griesinger,et al.  Peptide conformations. 42. Conformation of side chains in peptides using heteronuclear coupling constants obtained by two-dimensional NMR spectroscopy , 1987 .

[25]  K Wüthrich,et al.  Conformational polymorphism of cyclosporin A. , 1994, Structure.

[26]  Horst Kessler,et al.  Intestinal permeability of cyclic peptides: common key backbone motifs identified. , 2012, Journal of the American Chemical Society.

[27]  Armin Widmer,et al.  Peptide conformations. Part 31. The conformation of cyclosporin a in the crystal and in solution , 1985 .

[28]  G. Wider,et al.  Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy , 1991, Nature.

[29]  F. Seela,et al.  Different conformations of 1-deazaadenosine and its 2′-deoxyribonucleoside in the solid state and in solution , 1999 .

[30]  A. Bonvin,et al.  On the molecular basis of the recognition of angiotensin II (AII). NMR structure of AII in solution compared with the X-ray structure of AII bound to the mAb Fab131. , 2003, European journal of biochemistry.

[31]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[32]  Horst Kessler,et al.  Reinvestigation of the Conformation of Cyclosporin A in Chloroform , 1990 .

[33]  H. Nar,et al.  High‐Resolution Crystal Structure of a Lasso Peptide , 2010, ChemMedChem.

[34]  E. M. Holt,et al.  Conformational properties of 2,3‐methanopyroglutamic acid in peptides: Nmr and X‐ray diffraction studies , 1989, Biopolymers.